<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD11780000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P21730</UniProt_ID>
  <Seq_Length>350</Seq_Length>
  <Molecule_Weight>39336</Molecule_Weight>
  <KEGG_ID>hsa:728</KEGG_ID>
  <Orthology_ID>K04010</Orthology_ID>
  <Function_Summary>Receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a (PubMed:1847994, PubMed:8182049, PubMed:7622471, PubMed:9553099, PubMed:10636859, PubMed:15153520). The ligand interacts with at least two sites on the receptor: a high-affinity site on the extracellular N-terminus, and a second site in the transmembrane region which activates downstream signaling events (PubMed:8182049, PubMed:7622471, PubMed:9553099). Receptor activation stimulates chemotaxis, granule enzyme release, intracellular calcium release and superoxide anion production (PubMed:10636859, PubMed:15153520).</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>C5aR</Alias>
      <Alias>C5a anaphylatoxin chemotactic receptor</Alias>
      <Alias>C5a-R</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with anaphylatoxin C5a to initiate a change in cell activity.</Detail>
      <Keyword>C5a anaphylatoxin receptor activity</Keyword>
      <Ontology_ID>GO:0004944</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with the C5a product of the complement cascade to initiate a change in cell activity.</Detail>
      <Keyword>Complement component C5a receptor activity</Keyword>
      <Ontology_ID>GO:0004878</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptidoglycan stimulus. Peptidoglycan is a bacterial cell wall macromolecule.</Detail>
      <Keyword>Response to peptidoglycan</Keyword>
      <Ontology_ID>GO:0032494</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme MAP kinase by phosphorylation by a MAPKK.</Detail>
      <Keyword>Activation of MAPK activity</Keyword>
      <Ontology_ID>GO:0000187</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.</Detail>
      <Keyword>Response to lipopolysaccharide</Keyword>
      <Ontology_ID>GO:0032496</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A defense response that is mediated by cells.</Detail>
      <Keyword>Cellular defense response</Keyword>
      <Ontology_ID>GO:0006968</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The regrowth of a lost or destroyed organ.</Detail>
      <Keyword>Organ regeneration</Keyword>
      <Ontology_ID>GO:0031100</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.</Detail>
      <Keyword>Positive regulation of ERK1 and ERK2 cascade</Keyword>
      <Ontology_ID>GO:0070374</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>Activation of phospholipase C activity</Keyword>
      <Ontology_ID>GO:0007202</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptosis in neurons.</Detail>
      <Keyword>Negative regulation of neuron apoptosis</Keyword>
      <Ontology_ID>GO:0043524</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA Polymerase II (Pol II), originating at a Pol II-specific promoter.</Detail>
      <Keyword>MRNA transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0042789</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).</Detail>
      <Keyword>Chemotaxis</Keyword>
      <Ontology_ID>GO:0006935</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the concentration of calcium ions in the cytosol.</Detail>
      <Keyword>Elevation of cytosolic calcium ion concentration</Keyword>
      <Ontology_ID>GO:0007204</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The multiplication or reproduction of cells, resulting in the expansion of a cell population in the hindbrain.</Detail>
      <Keyword>Cell proliferation in hindbrain</Keyword>
      <Ontology_ID>GO:0021534</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.</Detail>
      <Keyword>Immune response</Keyword>
      <Ontology_ID>GO:0006955</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events required for an organism to receive a sensory chemical stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.</Detail>
      <Keyword>Sensory perception of chemical stimulus</Keyword>
      <Ontology_ID>GO:0007606</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.</Detail>
      <Keyword>Inflammatory response</Keyword>
      <Ontology_ID>GO:0006954</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.</Detail>
      <Keyword>Defense response to Gram-positive bacterium</Keyword>
      <Ontology_ID>GO:0050830</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of epithelial cell proliferation.</Detail>
      <Keyword>Positive regulation of epithelial cell proliferation</Keyword>
      <Ontology_ID>GO:0050679</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.</Detail>
      <Keyword>Neutrophil chemotaxis</Keyword>
      <Ontology_ID>GO:0030593</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>317</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>314</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>334</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>338</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>11</Position>
      <PTM_Type>Sulfotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>14</Position>
      <PTM_Type>Sulfotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>327</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>332</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MDSFNYTTPDYGHYDDKDTLDLNTPVDKTSNTLRVPDILALVIFAVVFLVGVLGNALVVWVTAFEAKRTINAIWFLNLAVADFLSCLALPILFTSIVQHHHWPFGGAACSILPSLILLNMYASILLLATISADRFLLVFKPIWCQNFRGAGLAWIACAVAWGLALLLTIPSFLYRVVREEYFPPKVLCGVDYSHDKRRERAVAIVRLVLGFLWPLLTLTICYTFILLRTWSRRATRSTKTLKVVVAVVASFFIFWLPYQVTGIMMSFLEPSSPTFLLLKKLDSLCVSFAYINCCINPIIYVVAGQGFQGRLRKSLPSLLRNVLTEESVVRESKSFTRSTVDTMAQKTQAV</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell surface</CellLocal>
      <Ontology_ID>GO:0009986</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Basolateral plasma membrane</CellLocal>
      <Ontology_ID>GO:0016323</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasmic membrane-bounded vesicle</CellLocal>
      <Ontology_ID>GO:0016023</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasmic vesicle</CellLocal>
      <Ontology_ID>GO:0031410</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Apical part of cell</CellLocal>
      <Ontology_ID>GO:0045177</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>C5AR1</Gene_Name>
    <Gene_Alias>C5AR; C5R1</Gene_Alias>
    <Gene_ID>728</Gene_ID>
    <Genbank_ACCN>NM_001736</Genbank_ACCN>
    <Protein_ACCN>NP_001727</Protein_ACCN>
    <HGNC_ID>1338</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/728</Gene_URL>
    <UCSC_ID>uc002pgj.1</UCSC_ID>
    <EMBL_ID>ENSG00000197405</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Systemic Lupus Erythematosus</Disease_Name>
      <Disease_Detail>Systemic Lupus Erythematosus</Disease_Detail>
      <Disease_DB>SYS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/systemic_lupus_erythematosus?search=C5AR1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypersensitivity Reaction Type Iii Disease</Disease_Name>
      <Disease_Detail>Hypersensitivity Reaction Type Iii Disease</Disease_Detail>
      <Disease_DB>HYP072</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypersensitivity_reaction_type_iii_disease?search=C5AR1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leukostasis</Disease_Name>
      <Disease_Detail>Leukostasis</Disease_Detail>
      <Disease_DB>LKS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leukostasis?search=C5AR1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sepsis</Disease_Name>
      <Disease_Detail>Sepsis</Disease_Detail>
      <Disease_DB>SPS077</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sepsis?search=C5AR1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lupus Erythematosus</Disease_Name>
      <Disease_Detail>Lupus Erythematosus</Disease_Detail>
      <Disease_DB>LPS004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lupus_erythematosus?search=C5AR1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tuberculosis</Disease_Name>
      <Disease_Detail>Tuberculosis</Disease_Detail>
      <Disease_DB>TBR010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tuberculosis?search=C5AR1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Complement Deficiency</Disease_Name>
      <Disease_Detail>Complement Deficiency</Disease_Detail>
      <Disease_DB>CMP009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/complement_deficiency?search=C5AR1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multiple Sclerosis</Disease_Name>
      <Disease_Detail>Multiple Sclerosis</Disease_Detail>
      <Disease_DB>MLT020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multiple_sclerosis?search=C5AR1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mannose-Binding Lectin Deficiency</Disease_Name>
      <Disease_Detail>Mannose-Binding Lectin Deficiency</Disease_Detail>
      <Disease_DB>MNN034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mannose_binding_lectin_deficiency?search=C5AR1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of C5a anaphylatoxin chemotactic receptor 1</PDB_Title>
      <PDB_ID>ASD11780000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04080</Pathway_ID>
      <Pathway_Title>Neuroactive ligand-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05150</Pathway_ID>
      <Pathway_Title>Staphylococcus aureus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04610</Pathway_ID>
      <Pathway_Title>Complement and coagulation cascades</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD11780001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2015-04-08</Create_Date>
</Organism_Record>